Because the 2011 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Association statement1 was based on a systematic literature search that ended in May, 2010, for this Review we searched for publications from May 1, 2010, through to April 28, 2016, on the Ovid platform in MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Abstracts and Reviews of Effects, and Cochrane Database of Systematic
ReviewDiagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
Introduction
The approval of medical treatments for idiopathic pulmonary fibrosis (IPF) marks a new era in approaching this deadly disease: offering hope to patients and their physicians, a clearer path forward for companies interested in the development of new treatments, and the potential for new biological insights. This new era also offers clinicians the opportunity to review approaches to diagnosis. The diagnostic criteria for IPF published by the American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Latin American Thoracic Association (ALAT) in 20111 have been crucial for defining entry criteria and ensuring appropriate recruitment for prospective clinical trials.2, 3, 4, 5, 6, 7 In turn, these trials, with large cohorts of well characterised patients, have provided considerable new clinically relevant information about disease presentation and its longitudinal behaviour.8, 9 The specific inclusion and exclusion criteria used in these studies have also highlighted the limitations of current diagnostic guidelines, and indicated opportunities for improvement.9, 10
The diagnosis of IPF requires the collaboration of multiple specialists, the ability to interpret and communicate complex clinical data patterns, and to integrate uncertain or sometimes conflicting information. The clinician interprets the history and physical examination of the patient to develop a clinical context, the thoracic radiologist interprets the pattern present on high-resolution CT images of the chest and, if needed, the pathologist interprets the histopathological pattern seen on lung biopsy samples. All the information gained must then be shared in a common language to enable clinical decision making. Since so-called classic clinical stories and patterns are uncommon, some degree of clinical uncertainty is often present, and acknowledgment of this limitation and a clear plan to address it are essential.
For this Review, we identified specific questions pertaining to the diagnosis of IPF (panel 1), and did a search of the medical literature to identify evidence related to the topics identified and that had been published after the 2011 ATS/ERS/JRS/ALAT guidelines.1 Using this research and the expert opinion of members of the Fleischner Society, we provide IPF diagnostic criteria that we believe will be useful for clinicians, clinical trialists, trial sponsors, and other interested groups.
Section snippets
Systematic review
An international multidisciplinary committee, including 17 members of the Fleischner Society with expertise in interstitial lung disease (ILD) and evidence-based medicine (eight pulmonologists, six radiologists, and three pathologists), and a medical librarian expert (SLK), developed the key questions believed to be important for the diagnosis of IPF (panel 1). Several face-to-face meetings were held, in addition to monthly conference calls. We did a literature search with the assistance of a
What specific clinical information is required to exclude other forms of ILD?
A diagnosis of IPF requires exclusion of alternative causes of fibrosing ILD, broadly grouped into systemic and exposure-related disorders. The clinical assessment requires an inquiring mind, a clear understanding of the differential diagnosis for IPF, and a comprehensive and structured approach to help exclude known causes and associations of fibrosing lung disease. A clear focus of a patient's clinical examination should be to establish the clinical probability of IPF, which is particularly
Imaging
CT plays a central role in the assessment of patients with ILD, and can be diagnostic in many situations. When IPF is considered in the differential diagnosis, the radiologist must indicate whether a UIP pattern is present and, if so, what their level of confidence is. Because of its importance, a systematic approach to CT of the chest in patients with suspected UIP is needed. This approach entails evaluation of image quality, precise assessment of specific disease features by use of standard
When is surgical or other biopsy indicated in the diagnosis of IPF?
The presence of a typical or probable UIP pattern on CT provides a diagnosis of IPF in the appropriate clinical context; no additional information is necessary, as discussed in the previous section. A surgical lung biopsy should be considered when the CT pattern is indeterminate or inconsistent with UIP, or when the clinical features suggest an alternative diagnosis (eg, exposures suggestive of hypersensitivity pneumonitis).
The current IPF guidelines1 do not adequately address the diagnostic
Guidance for multidisciplinary diagnosis
Multidisciplinary assessment of a patient with fibrotic ILD is important to establish the diagnosis and level of diagnostic confidence, determine the need for biopsy and other investigations, and help guide management. In the 2011 guidelines1 for the diagnosis and management of IPF, a multidisciplinary diagnosis consisted of the integration of views from radiologists, pathologists, and pulmonary specialists, primarily on the basis of a formulaic tabulated approach. However, the process of
Areas of uncertainty
The understanding of the diagnosis of IPF has many important gaps, and diagnostic guidelines will require regular revision. In this regard, several groups are working on combining imaging and clinical features to refine the assessment of the probability of IPF.11, 132 The clinical significance of atypical features on CT (eg, mosaic attenuation, apical pleuroparenchymal thickening) or by biopsy (eg, granulomas, PPFE) requires further clarification. More work is needed to understand the
Conclusions and recommendations
The clinical, imaging, and histological criteria for diagnosis of IPF continue to evolve. Panel 3 provides some diagnostic parameters that can be followed for patients with suspected IPF based on the clinical diagnostic confidence and radiological and pathological categories discussed in this Review. A diagnosis of IPF can be confidently made in a patient with a typical clinical context of IPF, with a CT pattern of typical or probable UIP. In all other circumstances, multidisciplinary diagnosis
Search strategy and selection criteria
References (137)
- et al.
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
Lancet Respir Med
(2014) - et al.
Autoimmune-featured interstitial lung disease: a distinct entity
Chest
(2011) - et al.
Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients
Respir Med
(2017) - et al.
Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis
Chest
(2013) - et al.
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis
Chest
(2013) - et al.
High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia
Chest
(2012) - et al.
Honeycombing on CT; its definition, pathologic correlation, and future direction of its diagnosis
Eur J Radiol
(2014) - et al.
Added value of prone CT in the assessment of honeycombing and classification of usual interstitial pneumonia pattern
Eur J Radiol
(2017) - et al.
A comparative study of honeycombing on high resolution computed tomography with histologic lung remodeling in explants with usual interstitial pneumonia
Pathol Res Pract
(2015) - et al.
CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis
Chest
(2015)
Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia
Chest
Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT
Clin Radiol
Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension
Chest
Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis
Eur J Radiol
Clinical findings and outcomes in patients with possible usual interstitial pneumonia
Respir Med
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia
Chest
The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study
Chest
Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease
Chest
Transbronchial biopsy in usual interstitial pneumonia
Chest
Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias
Chest
Pathologic comparison of video-assisted thoracic surgical lung biopsy with traditional open lung biopsy
J Thorac Cardiovasc Surg
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
Am J Respir Crit Care Med
The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes
Chest
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
N Engl J Med
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
N Engl J Med
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis
N Engl J Med
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
N Engl J Med
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
N Engl J Med
Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
Am J Respir Crit Care Med
Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia
Eur Respir J
The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
Thorax
Significance of connective tissue disease features in idiopathic interstitial pneumonia
Eur Respir J
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
Am J Respir Crit Care Med
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Eur Respir J
Autoimmune symptoms in idiopathic pulmonary fibrosis: clinical significance
Clin Respir J
CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features
AJR Am J Roentgenol
Hypersensitivity pneumonitis
Clinical diagnosis of hypersensitivity pneumonitis
Am J Respir Crit Care Med
Bird fancier's lung: a state-of-the-art review
Clin Rev Allergy Immunol
Fibrotic hypersensitivity pneumonitis: key issues in diagnosis and management
J Clin Med
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Eur Respir J
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease
Am J Respir Crit Care Med
Chronic interstitial pneumonia with honeycombing in coal workers
Sarcoidosis Vasc Diffuse Lung Dis
Pneumoconiosis-related lung cancers: preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis
Am J Respir Crit Care Med
Diffuse interstitial fibrosis in nonasbestos pneumoconiosis—a pathological study
Respiration
Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features
Radiology
The comparison of high-resolution computed tomography findings in asbestosis and idiopathic pulmonary fibrosis
Am J Ind Med
High-resolution CT of asbestosis and idiopathic pulmonary fibrosis
AJR Am J Roentgenol
Pulmonary fibrosis in the era of stratified medicine
Thorax
Clinical and pathologic features of familial interstitial pneumonia
Am J Respir Crit Care Med
Cited by (692)
Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand – A retrospective cohort study
2024, Seminars in Arthritis and RheumatismSevere SARS-CoV-2 pneumonia: HRCT findings after 6 months follow-up
2024, Journal d'imagerie diagnostique et interventionnelleChallenges in the diagnosis of interstitial lung disease
2024, Respiratory Investigation